“They are advancing messenger RNA for RSV, for Epstein-Barr, for influenza. … This biopharmaceutical complex appears to be hell-bent on messenger RNA technology, no matter how unsafe it is,” says Dr. Peter McCullough.
In this episode, we take a look at the latest evidence and research around the COVID-19 vaccines and mRNA vaccine technology, from ribosomal frameshifts to cancer risks.